Spark los­es an­oth­er top ex­ec in the wake of $4.3B takeover by Roche — re­port

Days af­ter bid­ding farewell to co-founder Kathy High, Spark Ther­a­peu­tics — now op­er­at­ing un­der Roche — has one more open­ing on its C-suite.

Kathy Reape

Kathy Reape, who joined the Philadel­phia-based biotech in 2016 as head of clin­i­cal R&D and be­came chief med­ical of­fi­cer in 2018, is re­port­ed­ly set to leave.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER